Header Logo

Connection

JAMUNARANI VEERARAGHAVAN to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about Clinical Trials, Phase III as Topic.
JAMUNARANI VEERARAGHAVAN
Connection Strength
0.037
Clinical Trials, Phase III as Topic
  1. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. J Natl Cancer Inst. 2020 01 01; 112(1):46-54.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.